SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-027816
Filing Date
2024-06-12
Accepted
2024-06-12 16:10:54
Documents
15
Period of Report
2024-06-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prme-20240612.htm   iXBRL 8-K 45776
2 EX-3.1 a06-12x2024xofficerexculpa.htm EX-3.1 13246
  Complete submission text file 0001628280-24-027816.txt   230839

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prme-20240612.xsd EX-101.SCH 2173
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prme-20240612_def.xml EX-101.DEF 15891
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prme-20240612_lab.xml EX-101.LAB 27927
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prme-20240612_pre.xml EX-101.PRE 16657
18 EXTRACTED XBRL INSTANCE DOCUMENT prme-20240612_htm.xml XML 3927
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41536 | Film No.: 241038515
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)